Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS??? EQUITY (Tables)

v3.22.1
STOCKHOLDERS’ EQUITY (Tables)
3 Months Ended
Mar. 31, 2022
Equity [Abstract]  
SCHEDULE OF OUTSTANDING STOCK WARRANTS ACTIVITIES

A summary of the status of the Company’s total outstanding warrants and changes during the year ended December 31, 2021 and the three months ended March 31, 2022 is as follows:

   

Number of

Warrants

   

Weighted

Average Exercise

Price

   

Weighted

Average

Remaining

Contractual

Life

(Years)

 
Balance at January 1, 2021     800     $ 300.00       1.37  
Granted     3,456,000       5.00       -  
Exercised     (925,908 )     (5.00 )     -  
Forfeited     -       -       -  
Cancelled     (800 )     (300.00 )     -  
Balance outstanding and exercisable at December 31, 2021     2,530,092     $ 5.00       4.42  
                         
Balance at January 1, 2022     2,530,092     $ 5.00       4.42  
Granted     -       -       -  
Exercised     -       -       -  
Forfeited     -       -       -  
Cancelled     -       -       -  
Balance outstanding and exercisable at March 31, 2022     2,530,092     $ 5.00       4.18  
SCHEDULE OF OUTSTANDING STOCK OPTIONS ACTIVITIES

A summary of the status of the Company’s outstanding stock options and changes during the three months ended March 31, 2022 is as follows:

 

    Number of
Options
    Weighted
Average Exercise
Price
    Weighted
Average
Remaining
Contractual
Life
(Years)
 
Balance at January 1, 2021     600,009     $ 2.35       9.91  
Granted    

400,000

                 
Exercised    

(19,200

)                
Forfeited    

(917

)                
Cancelled     (50,000 )                
Balance outstanding and excercisable at December 31, 2021     929,892     $ 3.53       7.36  
                         
Balance at January 1, 2022     929,892     $ 3.53       7.36  
Granted     -       -       -  
Exercised     -       -       -  
Forfeited     (191 )     -       -  
Cancelled     -       -       -  
Balance outstanding and excercisable at March 31, 2022     929,701     $ 3.42       7.12